Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis

BackgroundThe immune response and safety of inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among patients with chronic hepatitis B (CHB), especially those with cirrhosis, are not clear. Therefore, this study was conducted to evaluate the efficacy and safety of inac...

Full description

Bibliographic Details
Main Authors: Huanhuan Cao, Yufei Huang, Chunxiu Zhong, Xingmei Liao, Wenjuan Tan, Siru Zhao, Liangxu Guo, Rong Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2 vaccine
chronic hepatitis B
cirrhosis
immunogenicity
safety
liver injury
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1167533/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1167533/full

Similar Items